Otsuka Sues Indian Pharma Cos. Over Planned Abilify Generic
Otsuka Pharmaceutical Co. on Monday filed a complaint in New Jersey federal court alleging two India-based pharmaceutical companies and an American subsidiary are infringing two of its patents by seeking to...To view the full article, register now.
Already a subscriber? Click here to view full article